Belgian reimbursement system for medical devices and IVD tests
This online on-demand seminar gives a comprehensive understanding of the hospital reimbursement landscape for medical devices in Belgium. Additional modules cover reimbursement of IVD tests and medical aids
Provided in the form of a presentation in Acrobat PDF
Belgium is one of the rare countries in Europe that has a fee-for-service payment mechanism for hospital care. In addition to the INAMI fees for drugs, as well as physician and other services, hospitals also receive a budget for ward stay/other hospital activities.
The main goal of the market access activities for the majority of the procedures is the creation of the procedure code in the INAMI Nomenclature and inclusion into the List of reimbursable implantable and invasive devices. The role of the DRG is minor; APR-DRG is used only for a small number of low-variable procedures.
In addition, one Coverage with Evidence Development scheme exists, the goal of which is to provide temporary reimbursement in a limited number of centres to generate additional evidence to inform further decision-making about permanent reimbursement for implantable and invasive medical devices in Belgium.
It is essential for medical device and IVD companies to understand the pathways to the ultimate goal of reimbursement in Belgium. We offer a seminar on critical elements of the hospital reimbursement system for medical devices that can guide your decision-making in this complex country.
What topics are reviewed?
Key stakeholders and their role in reimbursement processes
Key stakeholders are reviewed, including payers (sickness funds), policy-makers (National Sickness and Invalidity Insurance Institution, INAMI/RIZIV)), decision influencers (Health Care Knowledge Centre, KCE)
Money flow, payment system, INAMI nomenclature and List of devices
Money flow and distribution of funds, INAMI nomenclature and List of devices, hospital conventions, role of DRG
Role of HTA, pathways to establish reimbursement
Role of Health Technology Assessment, different pathways to establish reimbursement, coverage with evidence development, pricing for medical devices
Additional modules
Reimbursement system for in-vitro diagnostic tests
A separate comprehensive overview of the reimbursement system for IVD tests in Belgium
Reimbursement system for medical aids
A separate comprehensive overview of the reimbursement system for medical aids in Belgium
What topics are not covered?
Some topics are not specifically covered in this seminar: reimbursement of health apps, funding of capital equipment
The introductory presentation also does not include details of reimbursement application processes (for example application form, requirements, details of the process for the inclusion of a new service in the INAMI/RIZIV nomenclature or adding a new device on the List)
Topics that are not covered in this seminar will be included in future courses. You can subscribe to our newsletter and inform us about your particular interests at the main page of the Market Access Academy
How is the seminar delivered?
Presentation in Acrobat PDF
At the moment, you can only access the educational material as the full presentation of the seminar in Acrobat PDF
Updates of the seminar
April 2020: Update of the overview of the Belgian IVD reimbursement system (new decision influencers introduced to the summary of stakeholders, new process of applying for reimbursement of new IVD tests, evidence requirements for the new process of applying for reimbursement for new IVD tests)
Request a quote
Click the button below to request a quote for the seminar
